Triple Negative Breast Cancer Trial

NCT00532727 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Carboplatin
DRUG: Docetaxel

Sponsor

Institute of Cancer Research, United Kingdom

Collaborators

[object Object]
[object Object]
[object Object]